SoToxa Oral Fluid drug testing device released to market and implemented after successful trails by Relevant and VIFM independent evaluation finds that is it compliant with AS/NZS 4760:2019, at this time the only electronic analyser to achieve this compliance.
As demand grew, particularly for court, custody and pre-employment testing, we implemented Hair Testing into our range of services.
Updated version of AS 4760 released and becomes joint Australian / New Zealand Standard AS/NZS 4760:2019. Procedure for specimen collection and the detection and quantification of drugs in oral fluid. Major changes include the requirement for informed consent, lowering of the THC (cannabis) cut-off level and the inclusion of Oxycodone.
We rebranded to Relevant Drug Testing Solutions to better reflect our range of services offered.
Due to demand from our clients, our breathalyser service division begins offering handheld breathalyser calibration, with industry leading turn around times.
We became the first Drug Testing agency in Australia to achieve NATA Quality Accreditation to then Australian Standard AS4760:2006 and Australian Standard ISO 15189 for onsite oral fluid testing using electronic analytical equipment.
The DrugTest 5000 was independently found to comply with the screening requirements as defined by the Australian Standard AS 4760:2006 by VIFM. We then purchased these devices to ensure we remained at the forefront of Oral Fluid Testing.
We trial the DDS2 device, Alere's third generation electronic drug detection system which provided portability and ease of use which the market had never seen before. After successful independent evaluation by VIFM, devices were purchased and used for oral fluid testing.
An updated version of AS/NZS 4308 for Urine Drug Testing is released as AS/NZS 4308:2008.
Our breathalyser service division is established initially servicing wall mounted breath alcohol testers.
Australian Standard AS 4760:2006 (Procedures for specimen collection and the detection and quantitation of drugs in oral fluid) released.
We expanded our operations into Queensland.
We commenced operation from humble beginnings in Hobart, Tasmania.
Joint Australian/New Zealand Standard AS/NZS 4308:2001 (Procedures for the collection, detection and quantitation of drugs of abuse in urine) released.
Prior to inception we researched methodologies for alcohol and other drug testing world wide and established, following extensive review, that the Cozart drug detection systems, were at the forefront of electronic analytical testing technology for drugs in oral fluid (saliva). During our research we were assisted by National Association of Testing Authorities (NATA) Accredited Laboratories and the Victorian Institute of Forensic Medicine (VIFM) led by Professor Olaf Drummer who subsequently became the chair of the Australian Standard AS4760:2006 which applies to oral fluid (saliva) drug testing.